Gastrointestinal Tumors
23
10
12
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.7%
2 terminated out of 23 trials
66.7%
-19.9% vs benchmark
9%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (23)
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
A Study of SKB571 in Participants With Gastrointestinal Tumors
A Study on Gastrointestinal Cancer Screening Using a Multi-Targeted Combined Detection Model
Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery
Opioid-free Anesthesia and Postoperative Delirium
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors
Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment
Combined Screening for Gastrointestinal Tumors
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
PD-L1 Targeting Molecular Imaging of Solid Tumors
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors
Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)
Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors